Rakesh N. Veedu
Murdoch University 90 South Street
Murdoch, WA 6150, Australia
Murdoch, WA 6150, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Survivin-Targeting Antisense Oligonucleotides in Cancer Therapy.
Journal: Molecules (Basel, Switzerland)
Published: April 14, 2026
An LNA gapmer antisense oligonucleotide inhibitor of human NNMT.
Journal: Molecular therapy. Nucleic acids
Published: December 01, 2025
Systematic evaluation of 2'-O-methyl RNA antisense oligonucleotides with limited phosphorothioate linkages for efficient splice switching.
Journal: Chemical communications (Cambridge, England)
Published: October 06, 2025
A single stereogenic center matters: Development of stereodefined anti-tau PMO-gapmers.
Journal: Molecular therapy. Nucleic acids
Published: September 10, 2025
Enhancing the intracellular delivery of antisense oligonucleotides (ASO) : a comparative study of aptamer, vitamin E, and cholesterol ASO conjugates.
Journal: RSC advances
Published: August 12, 2025
Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: August 05, 2025
BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans.
Journal: Molecular cancer
Published: July 08, 2025
Breaking barriers: Aptamers in ocular disease treatment.
Journal: Molecular therapy. Nucleic acids
Published: December 19, 2024
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: January 03, 2024
Splice-Switching Antisense Oligonucleotides Targeting Extra- and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer Cells.
Journal: Biomedicines
Published: October 27, 2023
Last Updated: 09/26/2026